CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 80 target
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03638687
NCT03638687N/ACompleted

Neuroimaging Epigenetics of Prospective Postpartum Depression Biomarkers

Johns Hopkins University·observational·Posted Aug 20, 2018·Updated Sep 22, 2020

In Brief

An observational study for Post Partum Depression and Bipolar Disorder. Completed, enrolled 80 participants across 1 site.

Detailed Summary

Through a recent cross species translational experiment, researchers have identified a set of epigenetic marks capable of predicting postpartum depression with greater than 85% accuracy. The researchers are looking to identify a group of women from both the general population and those with a history of mood disorders who are at risk for postpartum depression and obtain brain imaging data at a postpartum time period prior to the onset of depressive symptoms and compare it with those obtained during depressive episodes. The researchers will also evaluate the efficacy of postpartum depression biomarker prediction.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedAug 20, 2018
Enrollment StartMay 1, 2014
Primary CompletionOct 1, 2019
Study CompletionAug 1, 2020
TodayJul 2, 2026
Enrollment to primary: 5.4 yearsPosted 7.9 years ago